CRN 2019 ANNUAL REPORT - page 4

Return to main 2019 Annual Report page | Next page of Annual Report text

Influencing public policy on nutrition and health as it impacts dietary supplements and functional food.

CRN continued to build and maintain a positive legislative, regulatory and commercial environment for nutritional products to foster consumer confidence and industry growth.


CRN’s support of the SNAP Vitamin and Mineral Improvement Act of 2019, following up on intense efforts in 2018, provided a platform to spotlight research that underscores the nutritionally inadequate diets occurring more commonly in low-income Americans and position the multivitamin as a safe and affordable way to fill the gap—and as a foundation of wellness.

The Selective Androgen Receptor Modulator Control Act of 2019 builds on the success of another landmark piece of legislation, the Designer Anabolic Steroid Control Act of 2014, by enhancing the Drug Enforcement Administration’s authority to remove illegal Selective Androgen Receptor Modulators (SARMs) from the market. CRN continues to promote this legislation on Capitol Hill and via its #SARMsCanHarm campaign.

Working to establish a legal pathway to market for hemp-derived CBD, CRN supports supplementation not only to fill nutrient gaps but also to help achieve wellness and vitality, as more Americans seek health optimization.

Internationally, CRN engaged with the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) in pushing back on proposed harmonized probiotic guidelines for use in food and dietary supplements. Extensive lobbying by CRN and other key groups led to a request for a redraft of the proposal, effectively suspending decisive action for the year. This allows CRN to address concerns about duplicative, broad and/or unnecessary guidelines that could create  a trade barrier for probiotics and create restrictive precedent for other supplement ingredients.

Return to main 2019 Annual Report page | Next page of Annual Report text